Published in J Clin Pathol Suppl (Assoc Clin Pathol) on January 01, 1978
The mechanism of pancreatic secretion. J Physiol (1902) 15.82
The chemical mechanism of gastric secretion. J Physiol (1906) 7.11
THE CONSTITUTION AND PROPERTIES OF TWO GASTRINS EXTRACTED FROM HOG ANTRAL MUCOSA. Gut (1964) 6.71
Immunochemical evidence of cholecystokinin-like peptides in brain. Nature (1976) 2.67
New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature (1975) 2.62
Effect of secretin on serum gastrin as measured by immunoassay. Gastroenterology (1971) 2.40
Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients. Gut (1973) 1.97
And now, "big, big" gastrin. Biochem Biophys Res Commun (1972) 1.88
Heptadecapeptide gastrin: measurement in blood by specific radioimmunoassay. Gastroenterology (1976) 1.84
Zollinger-Ellison syndrome. Gastroenterology (1973) 1.79
Clearance and acid-stimulating action of human big and little gastrins in duodenal ulcer subjects. J Clin Invest (1976) 1.57
Antral-gastrin-cell hyperplasia in peptic-ulcer disease. Lancet (1974) 1.46
Differences in rates of gastrin release in normal persons and patients with duodenal-ulcer disease. N Engl J Med (1973) 1.43
The Bayliss-Starling lecture 1973. The gastrointestinal hormones: a review of recent advances. J Physiol (1974) 1.34
Relations between serum gastrin levels and rates of gastric hydrochloric acid secretion. N Engl J Med (1971) 1.28
Zollinger-Ellison syndrome type 1: clinical and pathological correlations in a case. Gut (1973) 1.27
Serum gastrin in patients with peptic ulceration. Br Med J (1970) 1.25
Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome). Hum Pathol (1975) 1.20
Enzymic iodination of the histidyl residue of secretin: a radioimmunoassay of the hormone. Biochim Biophys Acta (1973) 1.20
Plasma secretin and pancreatic bicarbonate response to exogenous secretin in man. Gut (1977) 1.19
Preparation and specificity of antiserum to synthetic secretin and its use in a radioimmunoassay (RIA). Endocrinology (1973) 1.13
Circulating gastrin in peptic ulcer disease. Mt Sinai J Med (1973) 1.08
Calcium-stimulated gastric secretion in the Zollinger-Ellison syndrome. Arch Surg (1970) 1.06
Failure of secretin release in patients with duodenal ulcer. Br Med J (1975) 1.05
Secretin: A new role for an old hormone. Lancet (1975) 1.02
Synthesis of a heptacosapeptide amide with the hormonal activity of sccretin. Chem Ind (1966) 1.01
Effects of intraduodenal administration of HCl and glucose on circulating immunoreactive secretin and insulin concentrations. J Clin Invest (1974) 0.97
Effect of graded amounts of acid instilled into the duodenum on pancreatic bicarbonate secretion and plasma secretin in duodenal ulcer patients and normal subjects. Gastroenterology (1977) 0.97
Impaired immunoreactive secretin release in coeliac disease. Br Med J (1977) 0.90
Starvation-induced changes in secretin-like immunoreactivity of human plasma. Biochim Biophys Acta (1979) 0.90
Gastric emptying of ingested acid and its effects on plasma gastrin and secretin in duodenal ulcer subjects. Scand J Gastroenterol (1978) 0.86
Letter: Antral-gastrin-cell hyperplasia in peptic ulcer disease. Lancet (1974) 0.81
Plasma-secretin during fasting. Lancet (1978) 0.77
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology (1995) 3.28
Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology (1997) 3.16
Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology (1999) 2.53
Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut (1993) 2.05
Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM (1996) 1.93
Neonatal secretion of gastrin and glucagon. Arch Dis Child (1974) 1.70
Hypercalcaemia in rheumatoid arthritis: investigation of its causes and implications. Ann Rheum Dis (1979) 1.58
Overexpression of the tumour suppressor gene p53 is not implicated in neuroendocrine tumour carcinogenesis. J Pathol (1995) 1.50
Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut (1999) 1.50
Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. Gastroenterology (1994) 1.50
Neuropeptide variability in man. Eur J Clin Invest (2000) 1.45
Effect of Helicobacter pylori eradication on antral somatostatin cell density in humans. Eur J Gastroenterol Hepatol (1998) 1.45
Is the secretion of atrial natriuretic peptide in man under neural control? Eur Heart J (2000) 1.39
Changing patterns in presentation and management of the Zollinger-Ellison syndrome in Northern Ireland, 1970-1988. Q J Med (1991) 1.39
Neuroendocrine tumors. A European view. Am J Med (1986) 1.29
Stimulation of gastrin release by catecholamines. Lancet (1972) 1.26
The frequency of gastrointestinal endocrine tumours in a well-defined population--Northern Ireland 1970-1985. Q J Med (1989) 1.25
Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging. QJM (1998) 1.23
Enzymic iodination of the histidyl residue of secretin: a radioimmunoassay of the hormone. Biochim Biophys Acta (1973) 1.20
Respiratory acidosis in hypothermic myxoedema coma. Postgrad Med J (1967) 1.17
Maturity onset diabetes mellitus: response to intensive dietary management. Br Med J (1975) 1.13
Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer. Gastroenterology (1996) 1.12
The acid response to gastrin distinguishes duodenal ulcer patients from Helicobacter pylori-infected healthy subjects. Gastroenterology (1998) 1.12
Triglyceride metabolism in acute starvation: the role of secretin and glucagon. Eur J Clin Invest (1976) 1.10
Abnormalities of glucagon metabolism in untreated diabetes mellitus. Lancet (1972) 1.10
Effect of blood glucose on glucagon secretion in anesthetized dogs. Diabetes (1969) 1.09
Hypergastrinaemia in rheumatoid arthritis: disease or iatrogenesis. Br Med J (1973) 1.08
The normal insulin response to glucose. The relationship between blood sugar and plasma insulin. Diabetologia (1967) 1.08
Cimetidine for duodenal ulceration in patients undergoing haemodialysis. Br Med J (1977) 1.07
Pancreatic glucagon release and sulphonylureas. Lancet (1969) 1.07
Carbohydrate metabolism in duodenal ulcer patients. Gut (1967) 1.07
Animal model to study the relationship between immunoreactive gastrin and inflammatory arthritis. Nature (1974) 1.06
A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut (1995) 1.05
Insulin control of glucagon release from insulin-deficient rat islets. Diabetes (1973) 1.05
Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17. Gut (1993) 1.04
Glucagonoma syndrome demonstrating giant duodenal villi. Gut (1984) 1.02
A glycoside-hydrolase inhibitor in treatment of dumping syndrome. Lancet (1979) 1.02
Secretin: A new role for an old hormone. Lancet (1975) 1.02
Effect of Helicobacter pylori on serum pepsinogen I and plasma gastrin in duodenal ulcer patients. Scand J Gastroenterol (1992) 1.01
Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis. Am J Med (1972) 1.00
Isolation of glucagon-like immunoreactivity of gut by affinity chromatography on anti-glucagon antibodies coupled to sepharose 4 B. Biochim Biophys Acta (1973) 1.00
Insulin and glucagon responses in subjects with pheochromocytoma: effect of alpha adrenergic blockade. J Clin Endocrinol Metab (1969) 0.99
Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest (1996) 0.99
A double antibody immunoassay for glucagon. Diabetes (1968) 0.99
Glucagon clearance by the isolated perfused rat liver. Proc Soc Exp Biol Med (1968) 0.98
Serum immunoreactive gastrin in rheumatoid arthritis. Further observations on its identity, clinical specificity, and relationship to gastric function. Ann Rheum Dis (1976) 0.98
Appendiceal goblet cell carcinoids: a clinicopathological and immunohistochemical study. Histopathology (1991) 0.97
Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM. Diabetes (1996) 0.96
Variable patterns of atrial natriuretic peptide secretion in man. Eur J Clin Invest (1994) 0.94
Antibodies to unconjugated synthetic and natural secretins. Horm Metab Res (1972) 0.94
High circulating levels of glucagon and gastrin in anephric subjects. N Z Med J (1976) 0.94
Isolation and primary structure of a novel chromogranin A-derived peptide, WE-14, from a human midgut carcinoid tumour. FEBS Lett (1992) 0.93
Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest (1991) 0.93
Treatment of peptic ulcer in renal failure. Proc Eur Dial Transplant Assoc (1977) 0.93
Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53. J Pathol (1998) 0.92
Role of insulin in glucose intolerance in uraemia. Lancet (1967) 0.92
Effect of starvation and refeeding on serum immunoreactive glucagon and insulin levels. J Lab Clin Med (1968) 0.92
Helicobacter pylori-related hypergastrinaemia is not due to elevated antral surface pH. Studies with antral alkalinisation. Scand J Gastroenterol (1992) 0.91
Effect of fasting on glucose and insulin metabolism of obese patients. Lancet (1969) 0.91
Effect of acarbose on biochemical responses and clinical symptoms in dumping syndrome. Digestion (1985) 0.90
Impaired immunoreactive secretin release in coeliac disease. Br Med J (1977) 0.90
Starvation-induced changes in secretin-like immunoreactivity of human plasma. Biochim Biophys Acta (1979) 0.90
The tissue distribution of rat chromogranin A-derived peptides: evidence for differential tissue processing from sequence specific antisera. Histochemistry (1991) 0.90
Carbohydrate metabolism and pituitary function in gonadal dysgenesis (Turner's syndrome). J Endocrinol (1966) 0.90
A histological study of the effect of chronic gastritis on gastrin cell distribution in the human stomach. J Clin Pathol (1979) 0.90
Substance P and gastrin releasing peptide in bovine mesenteric lymphatic vessels: chemical characterization and action. Peptides (1989) 0.90
Effect of pancreozymin on insulin and glucagon levels in blood and bile. Am J Physiol (1968) 0.89
Effect of glucose concentration on insulin and glucagon release from isolated islets of Langerhans of the rat. Diabetes (1968) 0.89
Glucagon responses to arginine in chronic pancreatitis. Possible pathogenic significance in diabetes. Diabetes (1974) 0.89
Neuropeptides in psoriasis: an immunocytochemical and radioimmunoassay study. J Invest Dermatol (1991) 0.88
Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis. Cancer (1997) 0.88
Natural history of diabetes presenting age 40-69 years: a prospective study of the influence of intensive dietary therapy. Q J Med (1986) 0.88
Plasma lipids and gastro-intestinal hormones in subjects with gallstones. Horm Metab Res (1978) 0.88
Gastric emptying of a solid-liquid meal and gastro-intestinal hormone responses in patients with erosive oesophagitis. Digestion (1986) 0.87
Glucagon and insulin release. Influence of drugs affecting the autonomic nervous system. Diabetes (1971) 0.87
Euglycaemic hyperinsulinaemia does not affect gastric emptying in type I and type II diabetes mellitus. Diabetologia (1999) 0.87
Insulin and glucagon release from isolated islets of Langerhans. Effect of enteric factors. Diabetes (1969) 0.87
Glucagon and the gut. Gut (1971) 0.87
Glucagon release from isolated pancreas in streptozotocin-treated rats. Diabetes (1973) 0.87
Gastric corpus atrophy following eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol (2001) 0.86
Age dependent hypergastrinaemia in children with Helicobacter pylori gastritis--evidence of early acquisition of infection. Gut (1995) 0.86
Endocrine and exocrine pancreatic function in treated coeliac disease. Pancreas (1986) 0.86
Effect of carbenoxolone upon immunoreactive secretin in patients with rheumatoid arthritis. Lancet (1974) 0.86
Gastric emptying of ingested acid and its effects on plasma gastrin and secretin in duodenal ulcer subjects. Scand J Gastroenterol (1978) 0.86
Radioimmunoassay for pancreatic polypeptide, and its age-related changes in concentration. Clin Chem (1983) 0.86
Role of gastrointestinal hormones in the response to massive resection of the small bowel. Gut (1977) 0.86
Immunoreactivity to the pancreatic polypeptide family in the nervous system of the adult human blood fluke, Schistosoma mansoni. Cell Tissue Res (1990) 0.85
The regional distribution of neuropeptides in human skin as assessed by radioimmunoassay and high-performance liquid chromatography. Clin Exp Dermatol (1994) 0.85
Hypersecretion of insulin, glucagon and gastrin in a kindred with multiple adenomatosis. Diabetes (1968) 0.85
Circulating gastrointestinal hormone changes in marathon running. Int J Sports Med (1995) 0.85
Immunoreactive gastrin and gestation. Am J Obstet Gynecol (1975) 0.85
Hyperglycaemia and mortality from acute stroke. Q J Med (1993) 0.85
Distribution of atrophy in Helicobacter pylori-infected subjects taking proton pump inhibitors. Scand J Gastroenterol (2000) 0.84
The epidermal nerve fibre network: characterization of nerve fibres in human skin by confocal microscopy and assessment of racial variations. Br J Dermatol (1997) 0.84
Plasma insulin studies in two hundred patients with diabetes mellitus. Q J Med (1969) 0.84